Corteria team is very proud to announce the initiation of COR-1167 first-in-human study. COR-1167 is a first-in-class corticotropin-releasing hormone receptor 2 (CRF2) agonist. A significant milestone toward a treatment for worsening heart failure.
Full PR is available here :https://corteriapharma.com/wp-content/uploads/2024/03/Corteria-PR-FIM-COR-1167-EN.pdf